DRUG STUDY

CRITERIA:
Content and organization 40% Analysis
40% Neatness and promptness 10%
Reference 10% TOTAL 100%
DAVAO DOCTORS COLLEGE
General Malvar St., Davao City
Nursing Program

Name of Patient: N/A Date of Admission: _N/A Room: N/A Age: _N/A Sex: _N/A

Civil Status: N/A Attending Physician: N/A

DRUG NAME CLASSIFICATION/ INDICATION CONTRAINDICATIONS ADVERSEREACTION/ NURSING RESPONSIBILITY

BRAND NAME:
TRYCEF
GENERIC NAME:
CEFOTAXIME
DOSAGE:
Adults: 1g IM or IV 30-90
minutes before surgery.
Adults and children weighing
>50kg: 1 to 2 g IVV or IM
Children ages 1 month to 12
years weighing <50kg: 50 to
180mg/kg/day IM or IV
Neonates ages 1 to 4 weeks:
50mg/kg IV
ROUTE:
INTRAVENOUS,
MECHANISM OF
SIDE EFFECT
ACTION
CNS: Fever, Headache. - Check doctors order for Right
- Treatment for lower - Contraindicated in patients with
CLASSIFICATI Medication, right dosage, right route
respiratory tract hypersensitive to drug or
ON: HEENT: Hearing loss. and right patient.
Therapeutic infection. other cephalosporins.
- Obtained baseline vital signs prior to
Class: - Treatment for pelvic - Use cautiously in patients CV: Phlebitis, Thrombophlebitis. giving medication.
Antibiotics inflammatory. hypersensitive to penicillin - Explain to the patient the importance
Pharmacologic because of possibility of GI: Diarrhea, Nausea and Vomiting. of the drug.
class: Third - Treatment for
cross-sensitivity with other - Monitor patient for diarrhea and treat
Generation endometritis.
beta-lactam antibiotics. Hematologic: Agranulocytosis, appropriately.
cephalosporins. - Treatment skin and
- Prolonged use may result in Thrombocytopenia, Transient neutropenia, - Monitor patients’ renal function
skin structure Eosinophilia, Hemolytic Anemia. through intake and output.
fungal or bacterial
infection. - Tell the patient to promptly report the
superinfection, including
MECHANISM - pseudomembranous colitis, SKIN: Maculopapular and erythematous adverse reactions and sings and
OFACTION: which can occur more than 2 rashes, Urticaria, Pain, Temperature symptoms of superinfection
months after treatment elevation, tissue sloughing at IM injection including diarrhea.
Inhibits cell-wall ends. site. - Instruct the patient to report
synthesis, discomfort at IV insertion site.
promoting - Use cautiously in patients with Others: Anaphylaxis, Hypersensitivity
- Instruct patient to notify physician
osmotic history of colitis or renal reaction, serum sickness.
instability; insufficiency. immediately of signs of superinfection,
usually
including black, furry overgrowth on
bactericidal.
tongue, vaginal itching or discharge,
and loose or foul-smelling stools.
- Always wash hands thoroughly and
disinfect equipment (whirlpools,
electrotherapeutic devices,
INTRAMUSCULAR treatment tables, and so forth) to
help prevent the spread of infection.
Employ universal precautions or
FREQUENCY: isolation procedures as indicated for
Adults and Children: q 6 to 8h specific patients.
Children ages 1 month to 12
years: 4 to 6 divided doses
Neonates ages 1 to 4 weeks:
q8h.
Neonates ages 1 week: q 12h.

SOURCE: 42nd
Edition, Nursing
Drug Handbook
Philippine Edition,
2022, 291p-292p
Wolters Kluwer.

PREPARED BY: SHIRNY FRENZ C. BARREDO, BSN II-